Back to FDA Applications sponsored by VANSEN PHARMA

FDA Drug Application 021222 by VANSEN PHARMA

Application Number021222
Application Type New Drug Application
Sponsor ApplicantVANSEN PHARMA
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP08/29/2001N3286000 8/29/2001
AP08/29/2001N3287000 8/29/2001
AP08/29/2001N3288000 12/7/2001
AP08/21/2002SE13284001 8/26/2002
AP08/21/2002SE13285001 8/21/2002
AP03/23/2004SLR8117003 3/28/2004
AP09/23/2009SLR23825006 11/12/2009
AP012/20/2005SLR13344009 1/6/2006
AP012/20/2005SLR13402009 1/19/2006
AP07/21/2008SCF20281012 7/23/2008
AP07/21/2008SCF20500012 8/5/2008
AP08/6/2012SLR33403013,s016ltr.pdf 8/7/2012
AP08/6/2012SLR33407013 8/7/2012
AP08/6/2012SLR33408016 8/7/2012
AP08/6/2012SLR33404016,s016ltr.pdf 8/7/2012

Back to FDA Applications sponsored by VANSEN PHARMA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.